Comparison of the clinical performance of Aptima HPV assay and the Cobas 4800 platform in women with normal cytology and positive high-risk HPV

Conclusion: We recommend analyzing the performances of hrHPV platforms in future larger s tudies in patients with normal cytology, rather than only cases with abnormal cytology.
Source: Acta Cytologica - Category: Cytology Source Type: research